Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.

Magrangeas F, Cherkaoui M, Bessonneau-Gaborit V, Derrien J, Chevalier C, Guérin-Charbonnel C, Diamond B, Samur MK, Intergroupe Francophone du Myélome (IFM), Hulin C, Caillot D, Karlin L, Arnulf B, Landgren O, Munshi NC, Avet-Loiseau H, Martinet L, Corre J, Perrot A, Moreau P, Touzeau C, Minvielle S, Letouzé E

Open source

DOI: 10.1038/s41591-026-04792-x
Published: 2026 Nov 3
Container: Nature medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04792-x,
  title = {Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.},
  author = {Magrangeas F and Cherkaoui M and Bessonneau-Gaborit V and Derrien J and Chevalier C and Guérin-Charbonnel C and Diamond B and Samur MK and Intergroupe Francophone du Myélome (IFM) and Hulin C and Caillot D and Karlin L and Arnulf B and Landgren O and Munshi NC and Avet-Loiseau H and Martinet L and Corre J and Perrot A and Moreau P and Touzeau C and Minvielle S and Letouzé E},
  year = {2026},
  journal = {Nature medicine},
  doi = {10.1038/s41591-026-04792-x},
  url = {https://doi.org/10.1038/s41591-026-04792-x}
}

RIS

TY  - JOUR
TI  - Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.
AU  - Magrangeas F
AU  - Cherkaoui M
AU  - Bessonneau-Gaborit V
AU  - Derrien J
AU  - Chevalier C
AU  - Guérin-Charbonnel C
AU  - Diamond B
AU  - Samur MK
AU  - Intergroupe Francophone du Myélome (IFM)
AU  - Hulin C
AU  - Caillot D
AU  - Karlin L
AU  - Arnulf B
AU  - Landgren O
AU  - Munshi NC
AU  - Avet-Loiseau H
AU  - Martinet L
AU  - Corre J
AU  - Perrot A
AU  - Moreau P
AU  - Touzeau C
AU  - Minvielle S
AU  - Letouzé E
PY  - 2026
JO  - Nature medicine
DO  - 10.1038/s41591-026-04792-x
UR  - https://doi.org/10.1038/s41591-026-04792-x
ER  -

APA

F, M., M, C., V, B., J, D., C, C., C, G., B, D., MK, S., (IFM), I. F. D. M., C, H., D, C., L, K., B, A., O, L., NC, M., H, A., L, M., J, C., A, P., P, M., C, T., S, M., & E, L. (2026). Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.. Nature medicine. https://doi.org/10.1038/s41591-026-04792-x

Source records

pubmed · retrieved 2026-11-10T20:18:07.875Z